Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.929 | 14 | 0 | 1994 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 1994 | 2012 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1994 | 2018 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1994 | 2007 | ||||||||
|
cytochrome P450 family 27 subfamily B member 1 | 0.502 | 0.769 | 1.9E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.080 | None | 0.625 | 8 | 0 | 1996 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1993 | 2002 | |||||||||
|
toll like receptor 3 | 0.427 | 0.885 | 1.6E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2014 | ||||||||
|
toll like receptor 7 | 0.464 | 0.885 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2012 | ||||||||
|
exosome component 10 | 0.839 | 0.154 | 2.0E-14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2007 | ||||||||
|
nucleoporin 62 | 0.470 | 0.885 | 0.95 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2016 | ||||||||
|
myoglobin | 0.556 | 0.731 | 3.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2018 | ||||||||
|
single-strand-selective monofunctional uracil-DNA glycosylase 1 | 0.322 | 0.923 | 4.5E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | ||||||||
|
general transcription factor IIH subunit 1 | 0.469 | 0.846 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
dysferlin | 0.582 | 0.692 | 3.7E-33 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2010 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2008 | 2018 | ||||||||
|
KH RNA binding domain containing, signal transduction associated 1 | 0.457 | 0.846 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
dynactin subunit 4 | 0.472 | 0.846 | 0.73 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2005 |